NIH-funded research NIH-funded research

Investigating how HIV and cocaine affect brain immune cells

Official title: Multimodal profiling of microglia during HIV infection and substance use disorder

Funded at University of Pennsylvania · NIH-10933539 · Data updated 2026-11-12

This study is looking at how HIV and cocaine use affect certain immune cells in the brain, with the goal of finding new ways to help people living with HIV avoid long-term brain problems.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 30, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$528,286
NIH project number5R61DA059917-02
Project IDNIH-10933539 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who also have a history of cocaine use or substance use disorders.

Less likely to help

Patients who do not have HIV or substance use disorders may not benefit from this research.

What this research studies

This research explores the effects of HIV infection and substance use disorders, particularly cocaine, on immune cells in the brain called microglia and macrophages. It aims to understand how HIV expression in these cells may lead to long-term neuropsychiatric damage, especially in individuals living with HIV. By examining the interplay between HIV and cocaine, the study seeks to identify potential new treatment targets that could improve patient outcomes. The research employs advanced techniques to profile these immune cells and their inflammatory states in response to HIV and cocaine exposure.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for neuropsychiatric issues in patients with HIV and substance use disorders.

How similar studies have gone: While some research has indicated the impact of cocaine on HIV dynamics, this study aims to fill significant knowledge gaps, making it a novel investigation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Jordan-Sciutto, Kelly L — University of Pennsylvania
  • Study coordinator: Jordan-Sciutto, Kelly L

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.